Temasek Holdings (Private) LTD Gracell Biotechnologies Inc. Transaction History

Temasek Holdings (Private) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$2.43 - $10.04 $760,777 - $3.14 Million	-313,077 Reduced 3.16%	9,588,863 $96.3 Million
Q3 2021 Nov 15, 2021	BUY	$9.91 - $14.84 $95.5 Million - $143 Million	9,638,782 Added 3662.74%	9,901,940 $137 Million
Q1 2021 May 17, 2021	BUY	$14.7 - $30.57 $3.87 Million - $8.04 Million	263,158 New	263,158 $4.05 Million

75.1K

Ticker GRCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,674,096
Description
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the tre...

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

Stay updated on Temasek Holdings (Private) LTD with notifications on news.